• 1
    Barre-Sinoussi F, Chermann JC, Rey F et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220:868871.
  • 2
    De Cock KM, Jaffe HW, Curran JW. The evolving epidemiology of HIV/AIDS. AIDS 2012; 26:12051213.
  • 3
    Mayer K, Beyrer C. WHO's new HIV guidelines: opportunities and challenges. Lancet 2013; 382:287288.
  • 4
    Mogensen TH, Melchjorsen J, Larsen CS, Paludan SR. Innate immune recognition and activation during HIV infection. Retrovirology 2010; 7:5473.
  • 5
    Brenchley JM, Schacker TW, Ruff LE et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749759.
  • 6
    Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373:123126.
  • 7
    Ranjbar S, Jasenosky LD, Chow N, Goldfeld AE. Regulation of Mycobacterium tuberculosis-dependent HIV-1 transcription reveals a new role for NFAT5 in the toll-like receptor pathway. PLOS Pathog 2012; 8:e1002620.
  • 8
    Moriuchi H, Moriuchi M, Fauci AS. Cathepsin G, a neutrophil-derived serine protease, increases susceptibility of macrophages to acute human immunodeficiency virus type 1 infection. J Virol 2000; 74:68496855.
  • 9
    Isegawa Y, Katahira J, Yamanishi K, Sugimoto N. Reactivation of latent human immunodeficiency virus 1 by human herpesvirus 6 infection. Acta Virol 2007; 51:1320.
  • 10
    Lathey JL, Spector DH, Spector SA. Human cytomegalovirus-mediated enhancement of human immunodeficiency virus type-1 production in monocyte-derived macrophages. Virology 1994; 199:98104.
  • 11
    Dobson-Belaire WN, Rebbapragada A, Malott RJ et al. Neisseria gonorrhoeae effectively blocks HIV-1 replication by eliciting a potent TLR9-dependent interferon-alpha response from plasmacytoid dendritic cells. Cell Microbiol 2010; 12:17031717.
  • 12
    Iwasaki A. Innate immune recognition of HIV-1. Immunity 2012; 37:389398.
  • 13
    Ploquin MJ, Jacquelin B, Jochems SP, Barre-Sinoussi F, Muller-Trutwin MC. Innate immunity in the control of HIV/AIDS: recent advances and open questions. AIDS 2012; 26:12691279.
  • 14
    Boasso A, Shearer GM. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin Immunol 2008; 126:235242.
  • 15
    Gougeon ML, Herbeuval JP. IFN-alpha and TRAIL: a double edge sword in HIV-1 disease? Exp Cell Res 2012; 318:12601268.
  • 16
    Grossman Z, Meier-Schellersheim M, Paul WE, Picker LJ. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat Med 2006; 12:289295.
  • 17
    Brenchley JM, Silvestri G, Douek DC. Nonprogressive and progressive primate immunodeficiency lentivirus infections. Immunity 2010; 32:737742.
  • 18
    Ganesan A, Chattopadhyay PK, Brodie TM et al. Immunologic and virologic events in early HIV infection predict subsequent rate of progression. J Infect Dis 2010; 201:272284.
  • 19
    Ford ES, Puronen CE, Sereti I. Immunopathogenesis of asymptomatic chronic HIV infection: the calm before the storm. Curr Opin HIV. AIDS 2009; 4:206214.
  • 20
    Mandl JN, Barry AP, Vanderford TH et al. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 2008; 14:10771087.
  • 21
    Doherty M, Ford N, Vitoria M, Weiler G, Hirnschall G. The 2013 WHO guidelines for antiretroviral therapy: evidence-based recommendations to face new epidemic realities. Curr Opin HIV AIDS 2013; 8:528534.
  • 22
    Douek DC, Picker LJ, Koup RA. T cell dynamics in HIV-1 infection. Annu Rev Immunol 2003; 21:265304.
  • 23
    Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11:373384.
  • 24
    Paludan SR, Bowie AG. Immune sensing of DNA. Immunity 2013; 38:870880.
  • 25
    Takaoka A, Wang Z, Choi MK et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007; 448:501505.
  • 26
    Unterholzner L, Keating SE, Baran M et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010; 11:9971004.
  • 27
    Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu YJ. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol 2011; 12:959965.
  • 28
    Hornung V, Ablasser A, Charrel-Dennis M et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009; 458:514518.
  • 29
    Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP–AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013; 339:786791.
  • 30
    Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009; 461:788792.
  • 31
    Freed EO, Martin MA. HIVs and their replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, eds. Field's virology. Philadelphia: Lippincot Williams & Wilkins, 2007:19712042.
  • 32
    Heil F, Hemmi H, Hochrein H et al. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 2004; 303:15261529.
  • 33
    Meier A, Chang JJ, Chan ES et al. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 2009; 15:955959.
  • 34
    Alter G, Suscovich TJ, Teigen N et al. Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells. J Immunol 2007; 178:76587666.
  • 35
    Gringhuis SI, van der Vlist, van den Berg LM, den Dunnen J, Litjens M, Geijtenbeek TB. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat Immunol 2010; 11:419426.
  • 36
    Solis M, Nakhaei P, Jalalirad M et al. RIG-I-mediated anti-viral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I. J Virol 2011; 85:12241236.
  • 37
    Berg RK, Melchjorsen J, Rintahaka J et al. Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNA. PLOS ONE 2012; 7:e29291.
  • 38
    Yan N, Regalado-Magdos AD, Stiggelbout B, Lee-Kirsch MA, Lieberman J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat Immunol 2010; 11:10051013.
  • 39
    Doitsh G, Cavrois M, Lassen KG et al. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 2010; 143:789801.
  • 40
    Gao D, Wu J, Wu YT et al. Cyclic GMP–AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 2013; 341:903906.
  • 41
    Jakobsen MR, Bak RO, Andersen A et al. IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proc Natl Acad Sci USA 2013; 110:E4571E4580.
  • 42
    Chang JJ, Altfeld M. Innate immune activation in primary HIV-1 infection. J Infect Dis 2010; 202 (Suppl. 2):S297S301.
  • 43
    Tilling R, Kinloch S, Goh LE et al. Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection. AIDS 2002; 16:589596.
  • 44
    Lempicki RA, Kovacs JA, Baseler MW et al. Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients. Proc Natl Acad Sci USA 2000; 97:1377813783.
  • 45
    Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005; 434:10931097.
  • 46
    Han Q, Zhang C, Zhang J, Tian Z. The role of innate immunity in HBV infection. Semin Immunopathol 2013; 35:2338.
  • 47
    Herbeuval JP, Nilsson J, Boasso A et al. Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. Proc Natl Acad Sci USA 2006; 103:70007005.
  • 48
    Herbeuval JP, Shearer GM. HIV-1 immunopathogenesis: how good interferon turns bad. Clin Immunol 2007; 123:121128.
  • 49
    Durudas A, Milush JM, Chen HL, Engram JC, Silvestri G, Sodora DL. Elevated levels of innate immune modulators in lymph nodes and blood are associated with more-rapid disease progression in simian immunodeficiency virus-infected monkeys. J Virol 2009; 83:1222912240.
  • 50
    Jacquelin B, Mayau V, Targat B et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 2009; 119:35443555.
  • 51
    Meier A, Alter G, Frahm N et al. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J Virol 2007; 81:81808191.
  • 52
    Selvaraj A, Pilakka-Kanthikeel S, Bhavani PK, Hanna LE, Pahwa S, Swaminathan S. Defective dendritic cell response to Toll-like receptor 7/8 agonists in perinatally HIV-infected children. Pathog Dis 2013; 69:184193.
  • 53
    Sachdeva N, Asthana V, Brewer TH, Garcia D, Asthana D. Impaired restoration of plasmacytoid dendritic cells in HIV-1-infected patients with poor CD4 T cell reconstitution is associated with decrease in capacity to produce IFN-alpha but not proinflammatory cytokines. J Immunol 2008; 181:28872897.
  • 54
    Pontillo A, Silva LT, Oshiro TM, Finazzo C, Crovella S, Duarte AJ. HIV-1 induces NALP3-inflammasome expression and interleukin-1beta secretion in dendritic cells from healthy individuals but not from HIV-positive patients. AIDS 2012; 26:1118.
  • 55
    Hernandez JC, Arteaga J, Paul S, Kumar A, Latz E. Urcuqui-Inc: up-regulation of TLR2 and TLR4 in dendritic cells in response to HIV type 1 and coinfection with opportunistic pathogens. AIDS Res Hum Retroviruses 2011; 27:10991109.
  • 56
    Doehle BP, Hladik F, McNevin JP, McElrath MJ, Gale M Jr. Human immunodeficiency virus type 1 mediates global disruption of innate anti-viral signaling and immune defenses within infected cells. J Virol 2009; 83:1039510405.
  • 57
    Hotter D, Kirchhoff F, Sauter D. HIV-1 Vpu does not degrade interferon regulatory factor 3. J Virol 2013; 87:71607165.
  • 58
    Bartovska Z, Beran O, Rozsypal H, Holub M. Antiretroviral treatment of HIV infection does not influence HIV-specific immunity but has an impact on non-specific immune activation. Curr HIV Res 2011; 9:8894.
  • 59
    Lange CG, Lederman MM, Madero JS et al. Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection. J Acquir Immune Defic Syndr 2002; 30:3340.
  • 60
    Plana M, Garcia F, Gallart T et al. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection. AIDS 2000; 14:19211933.
  • 61
    Pedersen KK, Pedersen M, Gaardbo JC et al. Persisting inflammation and chronic immune activation but intact cognitive function in HIV-infected patients after long-term treatment with combination antiretroviral therapy. J Acquir Immune Defic Syndr 2013; 63:272279.
  • 62
    Graham NM. The role of immunologic and viral markers in predicting clinical outcome in HIV infection. AIDS 1996; 10 (Suppl. 5):S2125.
  • 63
    Monroe KM, Yang Z, Johnson JR et al. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science 2014; 343:428432.
  • 64
    Rasaiyaah J, Tan CP, Fletcher AJ et al. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 2013; 503:402405.
  • 65
    Lahaye X, Satoh T, Gentili M et al. The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 2013; 39:11321142.
  • 66
    Wei W, Clarke CJ, Somers GR et al. Expression of IFI 16 in epithelial cells and lymphoid tissues. Histochem Cell Biol 2003; 119:4554.
  • 67
    Li XD, Wu J, Gao D, Wang H, Sun L, Chen ZJ. Pivotal roles of cGAS–cGAMP signaling in anti-viral defense and immune adjuvant effects. Science 2013; 341:13901394.
  • 68
    Rathinam VA, Jiang Z, Waggoner SN et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 2010; 11:395402.